INSIGHTS ON CONTRACT PHARMA MANUFACTURING
-
![GettyImages-1269956871 vial bottle]( "Overcoming Challenges To High-Concentration Formulation Development")
Overcoming Challenges To High-Concentration Formulation DevelopmentExplore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
![Europe Globe Map Data GettyImages REV-1319209608]( "Global Experts, Local Presence: Strengthening Europe's Advanced Therapy Supply Chain")
Global Experts, Local Presence: Strengthening Europe's Advanced Therapy Supply ChainEnsure the seamless development and commercialization of your ATMPs in Europe with integrated supply chain solutions that optimize logistics, biostorage, and regulatory compliance.
-
![New Packaging Strategy Optimizes Supplies And Prevents Break In Enrollment]( "The Gateway To Europe: How The Stevenage Supply Chain Hub Supports ATMP Development")
The Gateway To Europe: How The Stevenage Supply Chain Hub Supports ATMP DevelopmentEnsure seamless access to European clinical trials and markets with GMP-compliant logistics, regulatory support, and risk mitigation to protect the integrity of your advanced therapies.
-
![GettyImages-1634050535 data, logistics]( "How Our Recent Innovative Solutions Meet Today's Supply Chain Challenges")
How Our Recent Innovative Solutions Meet Today's Supply Chain ChallengesWhen advanced therapy organizations place innovation at the heart of their strategy for overcoming supply chain challenges, they ultimately prioritize the most important stakeholder — the waiting patient.
-
![bora future thumb]( "Bora Pharmaceuticals: A Future Focused CDMO")
Bora Pharmaceuticals: A Future Focused CDMOSpecializing in formulation development, clinical and commercial manufacturing, and advanced packaging solutions, we bring expertise across a diverse range of dosage forms.
-
![inseption group charge trial thumb]( "Who's In Charge? How To Ensure Effective Trial Oversight, Leadership")
Who's In Charge? How To Ensure Effective Trial Oversight, LeadershipGain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.
-
![curia imaging thumb]( "One-Step SAR: Using High-Content Imaging To Drive Small Molecule Protein Degraders From Hit To Lead")
One-Step SAR: Using High-Content Imaging To Drive Small Molecule Protein Degraders From Hit To LeadDiscover Curia’s cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data.
-
![GettyImages-1572385009 production, facility, manufacturing, pharma]( "The Question Of Quality: Digging Into Manufacturing Priorities For Viral Vectors")
The Question Of Quality: Digging Into Manufacturing Priorities For Viral VectorsAddressing the complexities of viral vector manufacturing through strategic internalization, advanced technologies, and regulatory excellence is crucial for the future of gene therapies.
-
![Getty Images-823447656-vector-viral-lab-AAV-cell-development]( "Developing Scalable, Global Solutions For Cell & Gene Manufacturing")
Developing Scalable, Global Solutions For Cell & Gene ManufacturingCell and gene therapies offer transformative potential for treating complex diseases, but their manufacturing and global delivery face significant challenges.
-
![GettyImages-166539104-cell-petri-gloves-lab-research]( "Streamline The Path To FIH Trials With Advanced Cell Line Development")
Streamline The Path To FIH Trials With Advanced Cell Line DevelopmentMany CDMOs cannot handle complex recombinant proteins, which often require a CLD process fully integrated with other CDMO components, including analytics and formulation development.
